161 related articles for article (PubMed ID: 23665841)
1. The apolipoprotein B/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease.
Emoto T; Sawada T; Morimoto N; Tenjin T; Wakimoto T; Ikeda F; Sato C; Terashita D; Mizoguchi T; Mizuguchi T; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
J Atheroscler Thromb; 2013; 20(7):623-9. PubMed ID: 23665841
[TBL] [Abstract][Full Text] [Related]
2. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B/A1 Ratio Is Associated with Severity of Coronary Artery Stenosis in CAD Patients but Not in Non-CAD Patients Undergoing Percutaneous Coronary Intervention.
Hua R; Li Y; Li W; Wei Z; Yuan Z; Zhou J
Dis Markers; 2021; 2021():8959019. PubMed ID: 34961824
[TBL] [Abstract][Full Text] [Related]
4. Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2010 Jan; 105(2):144-8. PubMed ID: 20102908
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population.
Hrira MY; Kerkeni M; Hamda BK; Chahed H; Ferchichi S; Addad F; Limam HB; Miled A
Cardiovasc Pathol; 2012; 21(6):455-60. PubMed ID: 22425626
[TBL] [Abstract][Full Text] [Related]
6. Plasma protein lipofuscin-like fluorophores in men with coronary artery disease treated with statins.
Sutherland WH; Williams MJ; de Jong SA
Arch Med Res; 2007 Oct; 38(7):757-63. PubMed ID: 17845895
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of acute infection-induced endothelial dysfunction and its potential mediators.
Kilickap M; Goksuluk H; Candemir B; Kaya CT; Ozcan OU; Turhan S; Vurgun K; Ozdemir AO; Erol C
Acta Cardiol; 2011 Oct; 66(5):581-7. PubMed ID: 22032051
[TBL] [Abstract][Full Text] [Related]
8. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
9. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
10. Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
Duan C; Du ZD; Wang Y; Jia LQ
World J Pediatr; 2014 Aug; 10(3):232-7. PubMed ID: 25124974
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein cholesterol/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study.
Tani S; Saito Y; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Nagao K; Hirayama A
Int Heart J; 2011; 52(6):343-7. PubMed ID: 22188706
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
13. Combined use of high-sensitivity C-reactive protein and apolipoprotein B/apolipoprotein A-1 ratio prior to elective coronary angiography and oral glucose tolerance tests.
Wen ZZ; Geng DF; Luo JG; Wang JF
Clin Biochem; 2011 Nov; 44(16):1284-91. PubMed ID: 21939649
[TBL] [Abstract][Full Text] [Related]
14. Serum apolipoprotein A1 rather than apolipoprotein B is associated with hypertension prevalence in Chinese people with coronary artery disease.
Dong H; Zhang Y; Hu P; Wang J; Lu N
Blood Press Monit; 2022 Apr; 27(2):121-127. PubMed ID: 34873074
[TBL] [Abstract][Full Text] [Related]
15. Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
Lind L
Atherosclerosis; 2007 Feb; 190(2):378-84. PubMed ID: 16545386
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
[TBL] [Abstract][Full Text] [Related]
17. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
18. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.
Ghorban K; Shanaki M; Mobarra N; Azad M; Asadi J; Pakzad R; Ehteram H
Hematology; 2016 Mar; 21(2):113-20. PubMed ID: 25913481
[TBL] [Abstract][Full Text] [Related]
19. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
Pan L; Lu G; Chen Z
Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
[TBL] [Abstract][Full Text] [Related]
20. The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population.
Jung CH; Hwang JY; Yu JH; Shin MS; Bae SJ; Park JY; Kim HK; Lee WJ
Clin Endocrinol (Oxf); 2012 Nov; 77(5):699-706. PubMed ID: 22211563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
